当前位置: 首页 > 详情页

Kindlin-2 interacts with beta-catenin and YB-1 to enhance EGFR transcription during glioma progression

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [2]Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [3]Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [4]Peking Union Med Coll, Beijing 100021, Peoples R China; [5]Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [6]Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China; [7]Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [8]South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [9]South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [10]China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China
出处:
ISSN:

关键词: EGFR glioma Kindlin-2 transcription

摘要:
Kindlin-2 promotes carcinogenesis through regulation of cell-cell and cell-extracellular matrix adhesion. However, the role of Kindlin-2 in glioma has not been elucidated. We investigated Kindlin-2 expression in 188 human glioma tissue samples. High Kindlin-2 expression was correlated with high pathological grade and a worse prognosis. Kindlin-2 promoted glioma cell motility and proliferation both in vitro and in vivo. Importantly, Kindlin-2 activated the EGFR pathway and increased EGFR mRNA levels. In addition to up-regulating Y-box binding protein-1 (YB-1) and beta-catenin expression, Kindlin-2 formed a transcriptional complex with YB-1 and beta-catenin that bound to the EGFR promoter and enhanced transcription. The beta-catenin/YB-1/EGFR pathway was required for Kindlin-2-mediated functions. Our data provide a better understanding of the mechanisms underlying glioma progression, and suggest that Kindlin-2 may be a biomarker and therapeutic target in glioma.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 3 区 细胞生物学
最新[2023]版:
JCR分区:
出版当年[2014]版:
Q1 ONCOLOGY Q1 CELL BIOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [2]Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [3]Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [4]Peking Union Med Coll, Beijing 100021, Peoples R China; [5]Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [6]Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China; [10]China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China
通讯作者:
通讯机构: [2]Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [3]Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [4]Peking Union Med Coll, Beijing 100021, Peoples R China; [6]Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院